chrisvoncsefalvay/vaers-outcomes huggingface dataset:
horriblemuscle pull from hip down.; PeriodicNumbness; tingling in right footand calf.; Very cloudy urine at firsturination of the day.; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old-male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534,) via an unspecified route of administration in the left arm on 17Mar2021 at 12:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had previously received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203,) via an unspecified route of administration into left arm on 24Feb2021 at 12:30 for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient did not receive any medications within 2 weeks of vaccination. Prior to vaccination the patient had not tested positive for COVID-19. No concomitant medications were reported. Since the vaccination, the patient had not diagnosed with COVID-19. On 17Mar2021 at 14:30, the patient had experienced horrible muscle pull in right leg from hip, periodic numbness and tingling in right foot and calf, very cloudy urine at first day of vaccination. The patient did not receive any treatment for the reported events. The clinical outcome of the events horrible muscle pull from hip down, periodic numbness, cloudy urine, tingling in right foot and calf was not resolved. No follow-up attempts are possible, no further information is expected.
I came into my home and sitting down and all of sudden I felt a dizziness come over me. It would not go away. I sat down for a few hours. Eventually it got enough that I could move around. I went to the urgent care the next morning. They examined me thinking my ears were clogged and gave me two pills for one day and Antivert and vitamin D3 two tabs a day. And I was told to follow up with the ENT doctor 12/14/2022. I feel I am functioning but on the right ear there is a stuffy feeling yet there is nothing in there. I am wondering if I am having any hearing issues. I do not know I did not have that checked.
Administration of only the diluent portion; Administration of only the diluent portion; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient was administered only the diluent portion of the shingrix vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not have info regarding the date of the administration nor gender or age of the patients. Agreed to be contacted for follow-up and claimed they would try to find more details about the event.  No further events were reported.  The reporter consented to follow up. This case was linked with US2021221646, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021221646:Same reporter. Patient 1.
Information has been received from a lawyer regarding a case in litigation concerning a 12 month old male child who on 9/26/02 was vaccinated IM with two doses of hepatitis B vaccine recombinant (yeast), lot # 633031/1667J given on 9/26/00, and lot #637175/1266K given on 11/14/00. An immunization record indicated that the patient was also vaccinated IM with four doses of alum, potassium, diphtheria toxoid, pertussis vaccine, tetanus toxoid (TRIPEDIA) lot #0898570 was given on 12/2/98, lot #0970140 was given on 2/16/99, lot #6916CB was given on 5/17/99 and lot #U00401CA was given on 9/26/00; four doses of HIB conjugate vaccine (ACTHIB) lot #1001170 given on 1/16/99, lot # N081BAA given on 4/16/99, lot #N1180AA given on 6/18/99, and lot # 00421 givein on 9/26/00; and one dose of HIB conjugate vaccine (HIBTITER) lot #473814 given on 9/26/00. It was noted that all of these vaccines contained the mercury laden preservative thimerasol. It is alleged that due to the accumulation of mercury in his body and the resultant mercury toxicity, the patient on or around October 1999, when he was approximately 12 months of age, suffered neurological devastation and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including , but not limited to, becoming withdrawn, unresponsive to his environment, engaging in repetitive behavior, and the loss of language skills. Upon internal review the patient's mercury toxicity, neurological devastation, withdrawn/unresponsive behavior, repetitive behavior and loss of language skills were determined to be other important medical events. Further information is expected.
This spontaneous report was received from a pharmacist refers to a 15 year old female patient. On 11-SEP-2014 the patient was inadvertently vaccinated with ZOSTAVAX. No adverse effects reported. The outcome was unknown. Additional information has been requested.
Pt developed intermittent shortness of breath around 3/7/21. Pt fell and had left arm and leg weakness. Pt had transient ischemic attack, multiple pulmonary emboli and deep venous thrombosis diagnosis on 3/27/21
PATIENT IS HAVING EXTREME PAIN IN LEFT ARM. PAIN NOT RELIEVED WITH ICING OR IBUPROFEN. PT HAS PREVIOUS HISTORY OF DAMAGE TO LEFT SHOULDER.
pt recv vax 12MAY97 & presented to ER w/a sore throat & uvula may have been swollen;given med;14JUN97 exp parotitis, genital & lower extremity edema;23JUN97 legs & genitals swollen;pitting edema, abd fullness;ascites;
Pain Lump/swelling on neck (left side) Lump/swelling on Armpit (left hand) Constant pain
contact dermatitis live rash w/pruritus/erythema @ site of inject 24 hrs p/inject;
All the lymph nodes on the right side of my neck and head were swollen sore and protruding,  I made an appointment with the Doctor the next day and the diagnosis was shingles.  I was prescribed an antiviral Valtrex which I am still taking.
3 day period of fatigue, muscle pain, headaches and flu like symptoms. No fever.  Muscle aches from hips to ankles persisted for 2 weeks with little relief from ibuprofen or naproxen. At the 2 week mark,  I was diagnosed with a bacterial sinus infection, took antibiotics for 5 days and felt relief by day 4. Then I caught another round of flu-like symptoms that lasted for 4 days and went straight into my typical allergy/hay fever symptoms.  I went in for updated allergy tests (last round was in 2014) and shockingly my previous allergies to pollen, weeds, dust mites, trees, cats, peanuts, etc. had all resolved and I was diagnosed with Non-allergic rhinitis. Now on daily flonase and astelin nose sprays for relief.
Shingles; A year or so later I took 2 more; I got the first shot/ I took 2 more; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles 6 years ago) and pain.   On an unknown date, the patient received the 1st dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 3rd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine and Shingles vaccine, the patient experienced shingles, drug dose administration interval too long and extra dose administered. On an unknown date, the outcome of the shingles, drug dose administration interval too long and extra dose administered were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had 1st dose 6 years ago and right side of the head was very painful. No pain medication helped. The reporter stated that, received 1st dose but it did not worked. A year or so later, the patient received 2nd dose of Shingrix late than the recommended time interval, which led to lengthening of vaccination schedule. The reporter stated that, received 2 shingles vaccine, which led to extra dose administered. The reporter stated that, a year or so took 2 doses more, it finally helped.
On 3/25/03 (day 4), pt. experienced chest pain.  On 3/27/03 she woke up at 3:00 am to let her dog out. She experienced an episode of significant shortness of breath.  She denies any history of chest pain or shortness of breath or cardiac disease, however she has a strong family history of cardisc disease. She has been experiencing some fatigue since these two episodes.  Prior to receiving the vaccine, she was switched from Zocor to Lipitor by her personal physician. On 3/27/03 she was evaluated by Dr. for the chest pain and shortness of breath symptoms.  He ruled out any diagnosis of cardiac disease.  She has experienced no other episodes of shortness of breath but still complains of mild fatigue.
This spontaneous report as received from a pharmacist refers to a friend of his wife of unknown age. On 2010 (reported as 3 or 4 years), the patient was vaccinated with ZOSTAVAX. On an unknown date she developed painful case of shingles on her face. The outcome of painful case of shingles on her face was unknown. This case is linked to 1408USA008634 due to same reporter link. Additional information has been requested.
Delayed hypersensitivity/ Covid arm --- large circular area of redness, warmth, swelling and itching at injection site (left deltoid)
Complaint of cough, chills, elevated temperature, sore/scratchy throat, headache, runny nose/congestion, myalgia, malaise, and diarrhea.
At the time of vaccination, the pt reported that she was not pregnant. At a later date, she reported that she was pregnant. "Death of child" was noted. In 10/00 an autopsy was performed on a male child with no reported genetic abnormalities. It was reported that the doctor did not have any information on the child or fetus and does not know if this was a miscarriage, stillbirth, or death after delivery. Additional information has been requested.  Follow up on 06/29/2001: "Lot number for vaccine 1 is not provided."
About 30minutes after injection and taking 400mg of ibuprofen, he returned to office with angioedema and hives on upper eyelids bilaterally.  No shortness of breath, no dizziness no nausea, no hives elsewhere on body.  10mg of Loratidine was given and he improved.
Since yesterday (04Oct2021), her face has started tingling; Fatigue went away a week after.; On same day, she had stuffy nose; She had slight headache,All of those symptoms went away; She was fatigued,She was very tired,Fatigue went away a week after; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Oct-2021 and was forwarded to Moderna on 05-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (On same day, she had stuffy nose), PARAESTHESIA (Since yesterday (04Oct2021), her face has started tingling), HEADACHE (She had slight headache,All of those symptoms went away), FATIGUE (She was fatigued,She was very tired,Fatigue went away a week after) and FATIGUE (Fatigue went away a week after.) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Sep-2021, the patient experienced NASAL CONGESTION (On same day, she had stuffy nose), HEADACHE (She had slight headache,All of those symptoms went away) and FATIGUE (She was fatigued,She was very tired,Fatigue went away a week after). On 30-Sep-2021, the patient experienced FATIGUE (Fatigue went away a week after.). On 04-Oct-2021, the patient experienced PARAESTHESIA (Since yesterday (04Oct2021), her face has started tingling). The patient was treated with EUCALYPTUS GLOBULUS OIL, MENTHOL (HALLS) for Adverse event, at an unspecified dose and frequency and IRON for Adverse event, at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (On same day, she had stuffy nose), PARAESTHESIA (Since yesterday (04Oct2021), her face has started tingling), HEADACHE (She had slight headache,All of those symptoms went away), FATIGUE (She was fatigued,She was very tired,Fatigue went away a week after) and FATIGUE (Fatigue went away a week after.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Blood pressure medicine and Diabetes medicine  Patient took Treatment with Halls, Vicks Vapor rub, Iron tablets
Injection Site Pain; Injection site swelling; Injection site abscess; Scarring; This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a adolescent female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, less than 2 months after receiving Bexsero, the patient experienced injection site pain, injection site swelling, injection site abscess and scar. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site abscess and scar were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site abscess and scar to be related to Bexsero.  Additional case details were provided as follows: The patient was 17 years or 18 years of age at the time of reporting. Age at vaccination was not reported. The patient had received 1st dose in an unknown arm and had an abscess, pain, swelling at injection site and scarring. The reporter stated that, the patient did come for her 2nd dose in about 30 days after this dose. The reporter agreed to follow up. This case has been linked to US2019AMR176855, reported for the same patient.
joint pain in my left hip/aggravated joint pain that lasted around 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain in my left hip/aggravated joint pain that lasted around 2-3 days) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 041B21A) for COVID-19 vaccination.     The patient's past medical history included Hip replacement. Family history included Arthritis.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joint pain in my left hip/aggravated joint pain that lasted around 2-3 days). At the time of the report, ARTHRALGIA (joint pain in my left hip/aggravated joint pain that lasted around 2-3 days) outcome was unknown.            No Concomitant informations were reported. No treatment informations were reported.   This case was linked to MOD-2021-310636 (Patient Link).
Within 10 minutes I had shooting pain up my right neck into my right jaw.  Shortly after I developed frontal headache.  I had injection site pain for 4-5 days.  My headache lasted almost 3 weeks.  I was tired and felt fluish for 5 days leading me to get a covid test on 12/27.  It was negative.  My entire body ached and I was hot all over starting day 4 through 8 or so.   My teeth would hurt at times  and so would my jaw.  This was intermittent for a few weeks.  I developed itching within a couple of hours after the injection that lasted for 3-4 days.  I had numbness and tingling in my hands and feet a few days after.  It turned into pain and itching.  My hands and feet still feel swollen, tight and hurt with occasional itching at times.
Headache, nausea, weakness, pale. Onset morning 11/18/2015 and unresolved as of this report on 11/19/2015 10 AM.  Severe enough to miss school.
MY PHARMACY STUDENT INTERN ADMINISTERED MODERNA BOOSTER 0.25ML TO A 9 YR OLD CHILD INSTEAD OF THE PFIZER 0.2ML (5-11YR) WHICH WAS ALREADY DRAWN UP AND SITTING ON TOP OF THE CHILDS CONSENT FORM.  THE CHILD MOM AND DAD WERE IN THE ROOM ALSO GETTING THEIR MODERNA BOOSTER VACCINES AND THE WRONG SYRINGE WAS GRABBED AND ADMINISTERED.  WE MONITORED THE CHILD FOR 20 MINUTES, SHE WAS ANXIOUS, BUT DOING FINE.  WILL CONTACT THE CHILDS PEDIATRICIAN TO INFORM THEM OF THE INCIDENT AND CONTACT THE PARENTS IN THE MORNING TO CHECK IN ON THE CHILD.
Patient stated that 2 hour after shot stated to develop "brain fog," fatigue, and pain/burning in injection arm. In am, was nauseated, slept all day, arm pain improved as did "brain fog."   Did not feel this was an allergic reaction, but  side effects that needed to be reported
RECEIVED FIRST DOSE OF PFIZER COVID VACCINE ON 02/03/21. REPORTED ER FALLING ON ICE WITH RIGHT HIP PAIN. ALSO HIT HEAD. IS ON BLOOD THINNER.  IN ER O2 SAT DROPPED AND WAS PLACED ON 4L OXYGEN. ADMITTED INPATIENT AFTER BEING DIAGNOSED WITH HYPOXIA, CHF, AND PELVIC FRACTURE
Upon administration of vaccine, I had muscle ache then coughing.  Coughing continue despite of cough suppressant then 12/30/2009- I had premature labor due to cervical incompetence that lead to hospitalization of 4 days however my son died and was delivered 01/01/2010, age of 21 weeks.  I STRONGLY BELIEVE THAT H1N1 VACCINE TRIGGERED A LOT OF COMPLICATION TO MY HEALTH THAT LEAD TO CERVICAL INCOMPETENCE BECAUSE THE ONLY MEDICAL INTERVENTION THAT I HAD WAS THE VACCINE.  I HAD MY DAUGHTER, NORMALLY DELIVERED AND IN MY FAMILY, MY MEDICAL HISTORY, WE DON'T HAVE THIS KIND OF ILLNESS DURING PREGNANCY.
One week after 1st Moderna vaccine, a large red rash, warm to touch and very sore developed at injection site. Significant rash lasted for over 2 weeks... arm was sore for 3-4 weeks and slight mark was visible. Doctor initially diagnosed as cellulitis and prescribed antibiotics (2 rounds...), which did not impact the rash. 6 weeks later and I can still feel where the reaction was, although the mark is gone. Two days after 2nd Moderna vaccine, the other arm had the same reaction. The rash was larger but only lasted about a week.  I was very run down for 2 days after 1st shot...  Chills,aches, etc for 2 days after the 2nd shot.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 11Apr2022 at 13:00 as dose 5 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2 single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 diabetes" (unspecified if ongoing); "glaucoma" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "known allergies: Penecilian" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01May2022) Negative, notes: Tested negative on rapid test five days after starting Paxlovid; (08May2022) Negative, notes: On day eight from first negative test symptoms returned tested negative twice on rapid tests; (08May2022) Negative, notes: On day eight from first negative test symptoms returned tested negative twice on rapid tests. Therapeutic measures were taken as a result of covid-19.  Clinical Course: The patient did not taken any other medication within two weeks of vaccination. Paxlovid in COVID 19 Treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported events Drug ineffective and COVID-19 which cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available.
Severe chills which caused shaking. It took him about 1&1/2 hours to get warmed up with blankets, warm wash clothes and heating pads.  He said at 4pm it stopped and he slept the rest of the day basically.  His neck did hurt slightly from shaking.  He took some Tylenol for that.
MMR and TDAP immuniz, swelling and redness at site more that small localized reaction.
No adverse event occurred today; patient received Pfizer 0.3ml BOOSTER at age 13 today.
Attack of spinal cord inflammation/transverse myelitis following 1st Pfizer vaccine. Attack was on 03/12/21. He was in his usual state of health on March 11 2021.  That day he went skiing and did not have any issues.  He was feeling well at 10 PM when he went to bed..  When he woke up at 3 AM on 3/12/2021 to go to the restroom he noticed his right leg felt weak.  He stumbled to the restroom.  Then he went back to sleep.  When he woke up again at 7 or 8 AM his right leg felt weaker.  He noticed balance issues, gait issues and bladder urgency more than usual.  He walked with difficulty using a cane and went to the ER.  He realized in the hospital that he had difficulty with writing due to coordination issues in the right upper extremity with some weakness.  He was having a lot of right leg spasms.
This case was reported by a nurse via call center representative and described the occurrence of therapy non-responder in a adult male patient who received ENGERIX B adult. Co-suspect products included ENGERIX B adult (batch number 3FZ74, expiry date unknown) and ENGERIX B adult (batch number 7S29F, expiry date unknown). On an unknown date, the patient received the 1st dose of ENGERIX B adult, the 2nd dose of ENGERIX B adult and the 3rd dose of ENGERIX B adult. On an unknown date, an unknown time after receiving ENGERIX B adult and ENGERIX B adult and 61 days after receiving ENGERIX B adult, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to ENGERIX B adult, ENGERIX B adult and ENGERIX B adult. Additional details provided were as follows: The registered nurse reported that, the patient completed a series of ENGERIX B adult vaccine on unspecified dates. On unknown date, 2 months after completing the vaccination series with ENGERIX B, the patient was tested negative for Hepatitis B surface antibody, causing the patient to be a non-responder to therapy. The reported batch number (3F274) for 2nd dose of ENGERIX B did not exist and was updated to 3FZ74 according to sales database. The reported batch number (7529F) for 3rd dose of ENGERIX B did not exist and was updated to 7S29F according to sales database as well. At the time of reporting, no further information was available.